Monitoring patients with precancerous stomach lesions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project focuses on identifying patients with precancerous lesions in the stomach to determine their risk of progressing to gastric cancer. It aims to stratify patients based on their risk levels and establish appropriate follow-up intervals for those at high risk. By implementing targeted endoscopic surveillance, the study seeks to improve early detection and management of gastric cancer, particularly in Latvia, where the incidence is high and late-stage diagnosis is common. The methodology includes upper endoscopy, biopsies, and sampling of plasma, serum, and fecal matter.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients undergoing upper endoscopy Motivation to participate in the study Signed consent

Exclusion Criteria:

Known gastric cancer Unwillingness or inability to co-operate

Where it's running

• University of Latvia
  Riga, Latvia Recruiting

Study contacts

• Study coordinator: Ilze Kikuste, PhD
• Email: ikikuste@gmail.com
• Phone: 28357349

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Collecting health information to understand and prevent gastric cancer

  This study is trying to gather health information from people with early signs of gastric cancer, as well as healthy individuals and those already diagnosed, to better understand what might lead to this type of cancer.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT06370143

• Mobile capsule gastroscopy for detecting stomach problems in older and high-risk people

  This project will test if an AI-assisted swallowable camera (mobile capsule gastroscopy) can find stomach diseases in older adults and people at higher risk.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07032961

• Monitoring patients with precursors to gastric cancer

  This study is testing the best ways to monitor people over 45 with early signs of stomach cancer to help keep them safe and healthy.

  Recruiting Instituto Portugues de Oncologia, Francisco Gentil, Porto · Porto · NCT04613570

• Breath testing for gastric cancer screening

  This study is testing if breath tests can help find gastric cancer and related conditions in people who have cancer, precancerous lesions, or are at average risk.

  Recruiting at 3 sites University of Latvia · São Paulo and 4 other locations · NCT04022109

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Epinephrine concentrations during gastric submucosal dissection in adults with gastric neoplasia

  This trial tests whether a lower dose of epinephrine (1:100,000) during gastric ESD works as well as a higher dose (1:500,000) to keep procedures efficient and safe in adults with gastric dysplasia or neoplasia.

  Recruiting Unidade Local de Saúde do Alto Ave, EPE · Guimarães, Braga District · NCT07920068

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.